Royalty Pharma plc has published the transcript of its Q4 2025 financial results conference call, held on February 11, 2026. The event was attended by key company executives including the Founder & Chief Executive Officer, the Chief Financial Officer, the Vice Chairman, and the Executive Vice President of Research & Investments, alongside several analysts from major financial institutions. During the call, management discussed the company's fourth-quarter and full-year 2025 financial results, highlighting the strength of their development-stage portfolio and the anticipated impact of upcoming data. The CEO noted, “It does highlight the incredible potential of our development-stage portfolio. We're really excited to see this.” He added, “After waiting a few years at this point for this event, as you might imagine, we are eager to see it and discuss the data with everybody.” The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief on February 17, 2026, and is solely responsible for the information contained therein.